Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Prestige Consumer Healthcare (PBH)
NYSE:PBH
RESEARCH TOOLSreports
PBH Stock Chart & Stats
Day’s Range― - ―
52-Week Range$60.00 - $86.36
Previous CloseN/A
Volume57.25K
Average Volume (3M)272.41K
Market Cap
$3.79B
Enterprise Value$4.61B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)18.7
Beta0.47
Next Earnings
Feb 06, 2025EPS Estimate
1.16Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)4.11
Shares Outstanding49,405,453
10 Day Avg. Volume268,971
30 Day Avg. Volume272,411
Standard Deviation0.07
R-Squared0.14
Alpha0.00772
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)3.41
Price to Cash Flow (P/CF)13.60
P/FCF Ratio13.30
Enterprise Value/Market Cap1.22
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit7.39
Enterprise Value/Ebitda13.05
Forecast
1Y Price Target
$92.33Price Target Upside21.33% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
---
Prestige Consumer Healthcare News
PremiumCompany Announcements
Prestige Consumer Healthcare Reports Stable Earnings Growth
PremiumCompany Announcements
Prestige Consumer Healthcare Reports Q3 2024 Financial Growth
PremiumPre-Earnings
Is PBH a Buy, Before Earnings?
PremiumCompany Announcements
Prestige Consumer Healthcare Reports Robust Q2 FY25 Results---
Bulls Say, Bears Say
Bulls Say
Financial PerformancePBH continues to generate significant cash flow due to its strong EBITDA margins and niche self-care product portfolio.
Management And StrategyThe appointment of Christine Sacco into the dual CFO/COO role indicates PBH's focus on M&A and enhancing operational integration.
Market PositionPBH's diverse OTC and self-care portfolio operates in niche categories, minimizing competition from major players.
Bears Say
Margin PressuresPrestige faces challenges in revamping Women's Health and driving international momentum, which could limit margin expansion.
Supply Chain ChallengesPBH experienced lower gross margins due to the use of air freight for the Clear Eyes brand, influenced by supply chain challenges.
Valuation ConcernsPBH's valuation is at an 18% premium to its 5-year average, suggesting that current market expectations may already factor in growth potential.
---
Ownership Overview
1.18% Insiders
42.75% Mutual Funds
0.60% Other Institutional Investors
27.56% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
PBH FAQ
What was Prestige Consumer Healthcare’s price range in the past 12 months?
Prestige Consumer Healthcare lowest stock price was $60.00 and its highest was $86.36 in the past 12 months.
What is Prestige Consumer Healthcare’s market cap?
Prestige Consumer Healthcare’s market cap is $3.79B.
When is Prestige Consumer Healthcare’s upcoming earnings report date?
Prestige Consumer Healthcare’s upcoming earnings report date is Feb 06, 2025 which is yesterday.
How were Prestige Consumer Healthcare’s earnings last quarter?
Prestige Consumer Healthcare released its earnings results on Feb 06, 2025. The company reported $1.22 earnings per share for the quarter, beating the consensus estimate of $1.167 by $0.053.
Is Prestige Consumer Healthcare overvalued?
According to Wall Street analysts Prestige Consumer Healthcare’s price is currently Undervalued.
Does Prestige Consumer Healthcare pay dividends?
Prestige Consumer Healthcare does not currently pay dividends.
What is Prestige Consumer Healthcare’s EPS estimate?
Prestige Consumer Healthcare’s EPS estimate is 1.16.
How many shares outstanding does Prestige Consumer Healthcare have?
Prestige Consumer Healthcare has 49,405,453 shares outstanding.
What happened to Prestige Consumer Healthcare’s price movement after its last earnings report?
Prestige Consumer Healthcare reported an EPS of $1.22 in its last earnings report, beating expectations of $1.167. Following the earnings report the stock price went up 3.156%.
Which hedge fund is a major shareholder of Prestige Consumer Healthcare?
Currently, no hedge funds are holding shares in PBH
---
Prestige Consumer Healthcare Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$92.33 (21.33% Upside)
$92.33 (21.33% Upside)
Blogger Sentiment
Bullish
PBH Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 8.9K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $12.0M over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
24.74%
12-Months-Change
Fundamentals
Return on Equity
12.61%
Trailing 12-Months
Asset Growth
-0.48%
Trailing 12-Months
Company Description
Prestige Consumer Healthcare
Prestige Consumer Healthcare, Inc. engages in the marketing, sale, and distribution of pharmaceutical drugs and consumer products. It operates through the following segments: North American OTC Healthcare, and International OTC Healthcare. The North American and International OTC Healthcare segments manages the following brands: BC/Goody's, Beano, Boudreaux's Butt Paste, Chloraseptic, Clear Eyes, Compound W, Debrox, DenTek, Dramamine, Efferdent, Fess, Fleet, Gaviscon, Hydralyte, Luden's, Monistat, Nix, Pedia-Lax, and Summer's Eve. The company was founded in 1996 and is headquartered in Tarrytown, NY.
---
PBH Company Deck
---
PBH Earnings Call
Q2 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presented a mixed outlook, with strong cash flow, EPS growth, and international segment performance offset by supply chain issues affecting Clear Eyes and resulting revenue declines. Management expressed confidence in overcoming these challenges and highlighted strategic initiatives to improve long-term performance.Read More>---
PBH Stock 12 Month Forecast
Average Price Target
$92.33
▲(21.33% Upside)
Technical Analysis
Church & Dwight
―
Colgate-Palmolive
―
Energizer Holdings
―
Johnson & Johnson
―
Kimberly Clark
―
Best Analysts Covering PBH
1 Year
1 Year Success Rate
10/11 ratings generated profit
1 Year Average Return
+10.56%
reiterated a buy rating 24 days ago
Copying Susan Anderson's trades and holding each position for 1 Year would result in 90.91% of your transactions generating a profit, with an average return of +10.56% per trade.
---